DiscoverCut the Chat Life Science InsiderResilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development

Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development

Update: 2025-06-19
Share

Description

In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead through complexity. Together they unpack the true meaning of biotech resilience - how a science-driven, patient-focused team turned unexpected data into a strategic partnership and renewed momentum.

Limor offers candid insight into neurodegenerative development, market expectations, and the power of staying mission-aligned through it all.

🎧 Subscribe to The Life Science Insider and follow Seuss+ for more behind-the-scenes biotech leadership stories.

Comments 
In Channel
Quality as Culture: Why Biotechs Can’t Afford to Get It Wrong

Quality as Culture: Why Biotechs Can’t Afford to Get It Wrong

2025-09-1832:58

Innovation, Execution, and Equity in RNA-Based Women’s Health

Innovation, Execution, and Equity in RNA-Based Women’s Health

2025-08-1542:45

Inside the Bid: What Sponsors Need to Know About CRO Pricing, Pressure & Proposals

Inside the Bid: What Sponsors Need to Know About CRO Pricing, Pressure & Proposals

2025-07-1741:36

Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development

Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development

2025-06-1928:16

Two Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)

Two Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)

2025-04-2228:00

AI in Biotech: Hype, Reality, and the Future of Drug Development

AI in Biotech: Hype, Reality, and the Future of Drug Development

2024-10-1630:03

Transforming Clinical Trials: How Digital Endpoints Are Leading the Way

Transforming Clinical Trials: How Digital Endpoints Are Leading the Way

2024-09-0435:57

Navigating the Commercialization Journey: Insights from Science to Market

Navigating the Commercialization Journey: Insights from Science to Market

2024-05-0727:36

Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions

Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions

2024-04-0335:10

Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics

Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics

2023-11-2929:05

Cross-Pollination and DEI Strategies with Ben Osborn

Cross-Pollination and DEI Strategies with Ben Osborn

2023-10-2534:09

Cracking the code: Navigating the Ever-Changing Biotech Landscape

Cracking the code: Navigating the Ever-Changing Biotech Landscape

2023-09-1331:54

Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy

Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy

2023-08-0930:38

Smart KPIs for Biotechs

Smart KPIs for Biotechs

2023-06-2933:45

Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development

Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development